• Reminder Regarding the Prohibited Use of Test Orders During the Pre-Open Period on Globex

      • To
      • Members, Member Firms and Market Users
      • From
      • Market Regulation Department
      • #
      • SER-7939
      • Notice Date
      • 07 June 2017
      • Effective Date
      • 07 June 2017

    • Market participants are reminded that the CME Group Market Regulation Advisory Notice on Rule 575 (“Disruptive Practices Prohibited”) prohibits entering an order(s) in a non-test product without the intent to execute a bona fide transaction, including for the purpose of verifying connectivity or checking a data feed. 

      Click HERE to view the full advisory.

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.